Tom Marjot's Avatar

Tom Marjot

@tom-marjot.bsky.social

Liver doctor. NIHR Academic Clinical Lecturer at University of Oxford. Interested in #MASLD, #circadian rhythms, & #sleep. #EASL YI Taskforce.

469 Followers  |  440 Following  |  11 Posts  |  Joined: 18.11.2024
Posts Following

Posts by Tom Marjot (@tom-marjot.bsky.social)

Programme for BASL MASLD SIG meeting 5th September 2025

Programme for BASL MASLD SIG meeting 5th September 2025

Venue details for BASL MASLD SIG meeting 5th September 2025

Venue details for BASL MASLD SIG meeting 5th September 2025

Really nice to be hosting the BASL #MASLD SIG at Jesus College Oxford on 5th September

πŸ“’Attendance is FREE and registration is EASY. There are still a few spaces left.
πŸ”—(tinyurl.com/4j8esadr)

Really great mix of speakers. AM = Basic/Translational science; PM = Clinical updates

11.08.2025 07:36 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Mechanism underpinning muscle pathology in MASLD and impact of exercise on liver histology

Mechanism underpinning muscle pathology in MASLD and impact of exercise on liver histology

πŸ”— shorturl.at/aFO1Q

25.05.2025 12:04 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Graphic showing assessment methods for various domains of muscle quality and function in patients with MASLD including insulin resistance, myosteatosis, sarcopenia, and frailty.

Graphic showing assessment methods for various domains of muscle quality and function in patients with MASLD including insulin resistance, myosteatosis, sarcopenia, and frailty.

πŸ“’Great to write this review for Hep Comms with Matt Armstrong & @jonathanstinemd.bsky.social

πŸ’ͺWe've covered everything you need to know about #Muscle & #MASLD
- Insulin resistance
- Sarcopenia
- Myosteatosis
- Impact of weight loss drugs
- Benefits of exercise

πŸ”— shorturl.at/aFO1Q

#LiverSky

25.05.2025 12:02 β€” πŸ‘ 11    πŸ” 2    πŸ’¬ 1    πŸ“Œ 0
Preview
Skeletal muscle and MASLD: Mechanistic and clinical insights : Hepatology Communications , which all converge on the liver to drive disease progression and adverse patient outcomes. This review explores the mechanistic links between skeletal muscle and MASLD, including the role of abnorma...

It was an absolute delight to contribute to this high-impact work with @tom-marjot.bsky.social and @mattarmstrong95.bsky.social in which we review all things #MASLD and #Muscle!

If you're looking for holiday weekend reading, look no further:

journals.lww.com/hepcomm/page...

@ebtapper.bsky.social

23.05.2025 20:41 β€” πŸ‘ 8    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image

BS @easlnews.bsky.social Congress

Wed 7πŸ—“οΈWhole-day seminar plus a wet lab on spatial biology (NEW THIS YEAR‼️)
Thu 8πŸ—“οΈState of the Art by Lars Zender
Fri 9πŸ—“οΈMTE sessions on MASLD & MetALD
Sat 10πŸ—“οΈMicrobiome session co-chaired by our own @debbieshawcross.bsky.social

& more!πŸ”—https://tinyurl.com/4ky9r3x9

15.04.2025 15:55 β€” πŸ‘ 9    πŸ” 4    πŸ’¬ 1    πŸ“Œ 0

In these unprecedented dark times for American life science and medical research (no less well beyond biomedicine), my coping mechanism is to laser focus on the unremitting and remarkable daily advances, and the fervent hope these will not be slowed or interrupted.

06.03.2025 21:34 β€” πŸ‘ 1285    πŸ” 152    πŸ’¬ 28    πŸ“Œ 10

#LiverSky

17.03.2025 13:53 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Original paper in @nature.com :
πŸ”—https://shorturl.at/jcWYE
πŸ‘ @gjpattij.bsky.social

BBJ article in Journal of Hepatology:
πŸ”—https://shorturl.at/4E2qT
@jhepatology.bsky.social
@easlnews.bsky.social

17.03.2025 13:48 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 0    πŸ“Œ 1
Highlights from latest article in Breakthroughs Beyond the Journal in Journal of Hepatology. It showcases work published in Nature.

Highlights from latest article in Breakthroughs Beyond the Journal in Journal of Hepatology. It showcases work published in Nature.

Breakthroughs Beyond the Journal @jhepatology.bsky.social

🚨The liver is central to fructose-associated cancer

▢️Tumors cannot use fructose directly
▢️Liver converts to specific lipids (LPC)
▢️LPCs integrate into new cancer membranes

Can this explain link between MASLD & extra-hepatic cancer?

17.03.2025 13:48 β€” πŸ‘ 6    πŸ” 1    πŸ’¬ 1    πŸ“Œ 2

There has been a recent influx to #gisky and #liversky

To sustain this, you need to be active. If you were a lurker, no we need your pearls, papers, and pets. Post. Use the hashtags. Build.

25.01.2025 14:05 β€” πŸ‘ 47    πŸ” 15    πŸ’¬ 2    πŸ“Œ 5
Post image

Young Investigator Poster Tour @easlnews.bsky.social #SLDSummit

Huge attendance and interest! πŸ‘πŸΌ

@tom-marjot.bsky.social @madsisraelsen.bsky.social

24.01.2025 13:42 β€” πŸ‘ 4    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Video thumbnail

2025 is the perfect year to take your career to the next levelπŸš€

There are also 6 positions to fill in the EASL Scientific Committee, Policy Public Health and Advocacy Committee, Ethics and Compliance Committee and Nurses & AHPs Task Force.

Apply by 20 January: easl.eu/leadership25

#LiverSky

15.01.2025 09:34 β€” πŸ‘ 12    πŸ” 5    πŸ’¬ 0    πŸ“Œ 0

By @adhanda.bsky.social & @tom-marjot.bsky.social

#Sharedit link: rdcu.be/d5rwu

06.01.2025 21:13 β€” πŸ‘ 9    πŸ” 5    πŸ’¬ 0    πŸ“Œ 0
Alcohol-free and low-strength drinks: friend or foe? - Nature Reviews Gastroenterology & Hepatology Consumption of no and low-alcohol (NoLo) beverages is now commonplace in modern society. However, the debate surrounding the relative risks and benefits of these products is nuanced and evolving, part...

Thoughtful piece from Marjot & Dhanda (@adhanda.bsky.social) in @natrevgastrohep.bsky.social: Alcohol-free drinks show promise for motivated individuals to reduce alcohol consumption but may pose relapse risks in others. Balance is key for clinical guidance. πŸ§ͺ
www.nature.com/articles/s41...

05.01.2025 14:16 β€” πŸ‘ 6    πŸ” 3    πŸ’¬ 2    πŸ“Œ 2

Do read my comment piece with @tom-marjot.bsky.social on NoLo alcohol πŸ‘‡πŸΎ

03.01.2025 21:46 β€” πŸ‘ 6    πŸ” 4    πŸ’¬ 1    πŸ“Œ 0
Preview
Myocardial infarction accelerates the progression of MASH by triggering immunoinflammatory response and induction of periostin Xie etΒ al. show that myocardial infarction (MI) accelerates the hepatic pathological progression of MASLD by promoting the production of CCR2+Ly6Chi monocytes, triggering hepatic immunoinflammatory response, and upregulating cardiac periostin contents, which in turn acts on hepatocytes and stellate cells to promote hepatic lipid accumulation and fibrosis.


πŸ”—Original paper from Xie et al.πŸ‘: shorturl.at/T6xkg

πŸ”—Breakthroughs Beyond the Journal: shorturl.at/8lae8

02.01.2025 12:34 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
New evidence of cross-disease communication between heart and liver

New evidence of cross-disease communication between heart and liver

1: In 2025, look out for a new section in Journal of Hepatology: "Breakthroughs Beyond the Journal". Editorial-style analyses of pivotal liver research. #LiverSky

2: My comment on work from Cell Metabolism showing that MI drives #MASH. The interaction between these two conditions works BOTH waysπŸ‘‡

02.01.2025 12:34 β€” πŸ‘ 12    πŸ” 1    πŸ’¬ 1    πŸ“Œ 0

Good to see you here @easlnews.bsky.social !

17.12.2024 08:50 β€” πŸ‘ 4    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Hello, #MedSky community! We’re excited to begin our Bluesky journey.

Here is a sampling of the trusted, influential, and essential information you can expect when you follow us:

06.12.2024 20:24 β€” πŸ‘ 862    πŸ” 188    πŸ’¬ 32    πŸ“Œ 48

#LiverSky Come join in T-minus 26 mins for EASL Studio! #Sarcopenia #Exercise #Nutrition #Frailty #MASLD #LiverTransplant

27.11.2024 16:36 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Tumor seeding is a dreaded complication of biopsy for HCC. But how common is it?

A systematic review in @amcollegegastro.bsky.social #AmJGastro reports a rate of tumor seeding of 0.62% with even lower rates in recent years

#LiverSky

Link: journals.lww.com/ajg/abstract...

27.11.2024 14:05 β€” πŸ‘ 19    πŸ” 9    πŸ’¬ 0    πŸ“Œ 0

#LiverSky

Useful tip...

There's no 'bookmark' function in Bluesky currently. But there is a nice work-around:

1) Reply to the post of interest with aπŸ“Œemoji
2) Click on this link bsky.app/profile/did:...
3) Click 'Pin to Home'

This will collateπŸ“Œposts in a tab on your home screen + ⬆️ engagement.

26.11.2024 12:11 β€” πŸ‘ 20    πŸ” 8    πŸ’¬ 9    πŸ“Œ 2

πŸ“Œ

26.11.2024 11:51 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

1/3 What happens when science and every day clinical practice comes together?

A 🧡

You get a packed room with not even a place to stand πŸ‘‡πŸΌ

Why?

I firmly believe that we need to bridge the gap between research and clinical application in our scientific meetings.

#TLM24

20.11.2024 00:55 β€” πŸ‘ 12    πŸ” 3    πŸ’¬ 1    πŸ“Œ 0
A figure from a scientific paper showing a single Flow Cytometry (FACS) panel. It looks like lots of dots in a square. Unexpectedly, some constellations of dots appear to be copy/pasted, and I have marked those with rounded boxes of the same color.

A figure from a scientific paper showing a single Flow Cytometry (FACS) panel. It looks like lots of dots in a square. Unexpectedly, some constellations of dots appear to be copy/pasted, and I have marked those with rounded boxes of the same color.

A figure from a scientific paper showing four Flow Cytometry (FACS) panels. Each looks like lots of dots in a square. Unexpectedly, some constellations of dots appear to be copy/pasted, and I have marked those with rounded boxes of the same color.

A figure from a scientific paper showing four Flow Cytometry (FACS) panels. Each looks like lots of dots in a square. Unexpectedly, some constellations of dots appear to be copy/pasted, and I have marked those with rounded boxes of the same color.

This artwork was published in the Journal of Immunology, published by @immunologyaai.bsky.social - which appears not to give a fork.
pubpeer.com/publications...
The Chinese government also did not see any problem.
www.science.org/content/arti...
#ThisImageIsFine

20.11.2024 02:15 β€” πŸ‘ 31    πŸ” 5    πŸ’¬ 3    πŸ“Œ 0
Bcounter Almost-real-time Bluesky user count

This is hypnotic

bcounter.nat.vg

19.11.2024 21:22 β€” πŸ‘ 153    πŸ” 33    πŸ’¬ 15    πŸ“Œ 4

We are on our second starter pack for GI / Hepatology
Part 1: go.bsky.app/8Pho2tp
Part 2: go.bsky.app/VGyLKjR

#medsky #GIsky #LiverSky

15.11.2024 15:17 β€” πŸ‘ 99    πŸ” 32    πŸ’¬ 23    πŸ“Œ 11